The Office of Fair Trading accuses GlaxoSmithKline of paying rivals to delay the release of generic versions of one of its drugs.

Source: http://www.bbc.co.uk/news/business-22212558#sa-ns_mchannel=rss&ns_source=PublicRSS20-sa

This entry was posted on Friday, April 19th, 2013 at 2:54 am and is filed under Business. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.